BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the share capital was represented at the virtual assembly. All ...
TMCnet

Noted Vaccine Researchers Ugur Sahin and Özlem Türeci Awarded Sabin Vaccine Institute's Albert B. Sabin Gold Medal; Genomic Scientist Senjuti Saha of Bangladesh Receives ...

The 2026 Sabin Awards were presented yesterday at the National Academy of Sciences building in Washington, D.C., with Professor Ugur Sahin, MD, and Professor Özlem Türeci, MD, receiving the Sabin ...
AOL

BioNTech's founding couple to quit to set up new venture

By Ludwig Burger FRANKFURT, March 10 (Reuters) - The two co-founders and leading executives of Germany's BioNTech will leave the COVID-19 vaccine maker by the end of 2026 to ‌start again with a new ...
Nasdaq

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

Mainz, Germany, January 12, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will provide a strategic business update and outline the Company’s focus areas for 2026, including an ...
STAT

BioNTech founders to depart, form new mRNA-focused company

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — The co-founders of the ...